NextCure, Inc.
NXTCNasdaqCIK 1661059HealthcareFiscal year ends Dec 31
Reports and events: 119 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2024-03-0816:34 ET | SC 13D/A | Ownership report, active investor, amended | 0000947871-24-000274 |
| 2023-12-1407:15 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001558370-23-019766 |
| 2023-11-0216:20 ET | 10-Q | Quarterly reportPeriod 2023-09-30 | 0001558370-23-017429 |
| 2023-11-0216:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001558370-23-017418 |
| 2023-08-0316:26 ET | 10-Q | Quarterly reportPeriod 2023-06-30 | 0001558370-23-013250 |
| 2023-08-0316:16 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001558370-23-013237 |
| 2023-07-1916:05 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001104659-23-082344 |
| 2023-06-2606:07 ET | 8-K | 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001104659-23-074450 |
| 2023-05-0416:30 ET | 10-Q | Quarterly reportPeriod 2023-03-31 | 0001558370-23-008131 |
| 2023-05-0416:20 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001558370-23-008118 |
| 2023-04-2816:09 ET | DEF 14A | Proxy statementPeriod 2023-06-22 | 0001104659-23-052945 |
| 2023-03-0216:41 ET | 10-K | Annual reportPeriod 2022-12-31 | 0001558370-23-002698 |
| 2023-03-0216:30 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001558370-23-002694 |
| 2022-11-0316:31 ET | 10-Q | Quarterly reportPeriod 2022-09-30 | 0001558370-22-016275 |
| 2022-11-0316:22 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001558370-22-016263 |
| 2022-08-0416:27 ET | 10-Q | Quarterly reportPeriod 2022-06-30 | 0001558370-22-012232 |
| 2022-08-0416:06 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-22-086121 |
| 2022-06-2317:01 ET | 8-K | 5.07 Shareholder vote results | 0001104659-22-073939 |
| 2022-05-0516:51 ET | 10-Q | Quarterly reportPeriod 2022-03-31 | 0001558370-22-007439 |
| 2022-05-0516:29 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-22-056484 |
| 2022-04-2916:06 ET | DEF 14A | Proxy statementPeriod 2022-06-23 | 0001104659-22-053530 |
| 2022-03-0317:01 ET | 10-K | Annual reportPeriod 2021-12-31 | 0001558370-22-002824 |
| 2022-03-0316:22 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-22-030025 |
| 2021-11-1516:13 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-21-139169 |
| 2021-11-0416:41 ET | 10-Q | Quarterly reportPeriod 2021-09-30 | 0001558370-21-014632 |
| 2021-11-0416:18 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-21-134399 |
| 2021-10-0416:06 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-21-122499 |
| 2021-09-2416:10 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001104659-21-119299 |
| 2021-08-0516:31 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-21-100794 |
| 2021-08-0516:29 ET | 10-Q | Quarterly reportPeriod 2021-06-30 | 0001558370-21-010578 |
| 2021-06-2516:05 ET | 8-K | 5.07 Shareholder vote results | 0001104659-21-085703 |
| 2021-05-0617:23 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-21-062513 |
| 2021-05-0616:39 ET | 10-Q | Quarterly reportPeriod 2021-03-31 | 0001558370-21-006266 |
| 2021-04-2916:19 ET | DEF 14A | Proxy statementPeriod 2021-06-24 | 0001104659-21-057620 |
| 2021-04-2617:11 ET | 10-K/A | Annual report, amendedPeriod 2020-12-31 | 0001104659-21-054980 |
| 2021-03-0416:34 ET | 10-K | Annual reportPeriod 2020-12-31 | 0001558370-21-002384 |
| 2021-03-0416:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-21-032110 |
| 2021-02-2417:14 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001104659-21-027570 |
| 2021-01-1416:33 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-21-004252 |
| 2020-11-0516:18 ET | 10-Q | Quarterly reportPeriod 2020-09-30 | 0001558370-20-012866 |
| 2020-09-1416:44 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-20-104856 |
| 2020-08-0616:14 ET | 10-Q | Quarterly reportPeriod 2020-06-30 | 0001558370-20-009660 |
| 2020-07-3116:19 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001104659-20-089093 |
| 2020-07-1716:51 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001104659-20-084546 |
| 2020-07-1316:28 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-20-083106 |
| 2020-06-1116:08 ET | 8-K | 5.07 Shareholder vote results | 0001104659-20-072403 |
| 2020-05-0717:30 ET | 10-Q | Quarterly reportPeriod 2020-03-31 | 0001558370-20-005800 |
| 2020-04-2706:02 ET | DEF 14A | Proxy statementPeriod 2020-06-11 | 0001047469-20-002583 |
| 2020-04-1418:12 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001123292-20-000663 |
| 2020-03-3007:12 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-20-039889 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 14, 2026, 20:17 ET. Listed shows no prices and gives no investment advice.